Show simple item record

dc.contributor.authorFitzGerald, Thomas J
dc.contributor.authorAronowitz, Jesse N.
dc.contributor.authorCicchetti, Maria Giulia
dc.contributor.authorFisher, Graeme
dc.contributor.authorKadish, Sidney P.
dc.contributor.authorLo, Y C.
dc.contributor.authorMayo, Charles
dc.contributor.authorMcCauley, Shelagh
dc.contributor.authorMeyer, Joshua
dc.contributor.authorPieters, Richard S.
dc.contributor.authorSherman, Alexandra
dc.date2022-08-11T08:10:32.000
dc.date.accessioned2022-08-23T17:12:25Z
dc.date.available2022-08-23T17:12:25Z
dc.date.issued2006-02-01
dc.date.submitted2017-04-21
dc.identifier.citation<p>Hematol Oncol Clin North Am. 2006 Feb;20(1):141-63. <a href="https://doi.org/10.1016/j.hoc.2006.01.005">Link to article on publisher's site</a></p>
dc.identifier.issn0889-8588 (Linking)
dc.identifier.doi10.1016/j.hoc.2006.01.005
dc.identifier.pmid16580561
dc.identifier.urihttp://hdl.handle.net/20.500.14038/46498
dc.description.abstractAs more patients are treated for their primary malignancy with cure or increased disease-free intervals, injury to normal tissues will become more detectable and an important endpoint for study. Future protocols will probably be modified based on toxicity endpoints. In Hodgkin's disease, current protocols use response-based treatment strategies to limit therapy. The objective is to provide the same level of tumor control and follow normal tissue endpoints for outcome analysis. DVH analysis has improved the ability to analyze endpoint data for normal tissues. These image-guided platforms will provide the infrastructure needed to continue efforts in improving the delivery of radiation therapy.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=16580561&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttp://dx.doi.org/10.1016/j.hoc.2006.01.005
dc.subjectHealth Services Administration
dc.subjectNeoplasms
dc.subjectOncology
dc.subjectRadiology
dc.subjectTherapeutics
dc.subjectTissues
dc.titleThe effect of radiation therapy on normal tissue function
dc.typeJournal Article
dc.source.journaltitleHematology/oncology clinics of North America
dc.source.volume20
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qarc/49
dc.identifier.contextkey10059147
html.description.abstract<p>As more patients are treated for their primary malignancy with cure or increased disease-free intervals, injury to normal tissues will become more detectable and an important endpoint for study. Future protocols will probably be modified based on toxicity endpoints. In Hodgkin's disease, current protocols use response-based treatment strategies to limit therapy. The objective is to provide the same level of tumor control and follow normal tissue endpoints for outcome analysis. DVH analysis has improved the ability to analyze endpoint data for normal tissues. These image-guided platforms will provide the infrastructure needed to continue efforts in improving the delivery of radiation therapy.</p>
dc.identifier.submissionpathqarc/49
dc.contributor.departmentDepartment of Radiation Oncology
dc.contributor.departmentQuality Assurance Review Center
dc.source.pages141-63


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record